Pharma News

ISTANBUL (Reuters) - Turkey increased on Wednesday the fixed exchange rate by 26.

TEL AVIV/NEW YORK (Reuters) - Teva Pharmaceutical Industries is “content” with having its new migraine drug Ajovy covered by nearly two-thirds of payers in the United States, Chief Executi...

New York-based Progenics last year picked up an FDA approval for its orphan radiotherapeutic.

Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for use on NHS Scotland.

Reeves is an associate professor in the School of Public Health and Health Sciences at the University of Massachusetts Amherst.

FOSTER CITY, Calif.

A Dr.

NEW YORK (Reuters) - Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.

Geneticists discovered a molecular trigger for a severe autism-related disorder that has enabled them to start testing a potential therapy targeting a specific protein in the brain.

The US Food and Drug Administration wants to be sure sketchy drugs don't find their way to hospitals and pharmacies, and it's mulling a technological solution to keep medicine safe.

Solid Biosciences' shares have taken a hit after early results from a study of SGT-001 microdystrophin gene transfer for the treatment of Duchenne muscular dystrophy (DMD) fell short.

Eisai and Purdue Pharma have announced six-month results from the SUNRISE 2 Phase III clinical study evaluating the efficacy and safety of lemborexant.